Voyageur Pharmaceuticals Ltd. announced a non-brokered private placement of up to unit 9,285,714s at an issue price of CAD 0.07 per unit for gross proceeds of up to CAD 650,000 on December 8, 2022. Each unit shall be comprised of one common share and one common share purchase warrant. Each warrant exercisable at CAD 0.12 for twenty-four months from closing.

The company may pay a cash commission or finder's fee to qualified non-related parties of up to 8% of the gross proceeds of the Offering (up to CAD 52,000) and issue broker warrants equal to up to 8% of the number of Units sold in the offering (up to 742,857 Broker Warrants). Each broker warrant will entitle the holder to acquire one common share at a price of CAD 0.07 per broker warrant for a period of one year from the date of issuance. The offering is being offered to all of the existing shareholders of company who are permitted to subscribe pursuant to the existing shareholder exemption.

This offer is open until January 31, 2023, or such other date or dates as the company determines and one or more closings are expected to occur, with the first closing anticipated for on or about December 21, 2022. Completion of the offering is subject to regulatory approval including, but not limited to, the approval of the TSX Venture Exchange. The common shares and warrants issued will be subject to a four month hold period from the date of the closing of the offering.

Insiders of the company may participate in the offering.